TNFRSF18 levels positively associated with expression of immune checkpoints CTLA4, PDCD1 as well as IL2RA and FOXP3 in both TCGA-LIHC (Figure 4F) and validation (Figure 4G) HCC cohorts. This evidence concerns the gene CTLA4 and hepatocellular carcinoma.